Description
Reg. No. G3774 (Act 36/1947)
Namibia Reg. No. V07/24.6/55 [NS0]
INDICATIONS
Equilis® Prequenza Te is indicated for the active immunisation of healthy horses and ponies against equine influenza. It reduces the severity and duration of clinical signs and reduces the amount and duration of viral shedding after infection. It is also indicated for the active immunisation against tetanus to prevent disease and mortality.
COMPOSITION
Equilis® Prequenza Te is a vaccine suspension, containing per 1 mℓ:
Purified haemagglutinin/neuraminidase subunits from equine influenza viruses:
– A/equine-2/ South Africa/4/03: 50 AU*
– A/equine-2/ Newmarket/2/93: 50 AU
Tetanus toxoid: 40 Lf**
Purified saponin (adjuvant): 375 µg
* Antigenic units
** Flocculation equivalents; corresponds with ≥ 30 IU/mℓ guinea pig serum in the Ph. Eur. potency test